A one-shot mRNA-LNP vaccine approach to prevent plague?
eBioMedicine · 2026-12 · 134 · 106567
DOI: 10.1016/j.ebiom.2026.106567 ↗Kurz gefasst
Fachartikel in der Zeitschrift eBioMedicine, 2026-12. Verfasst von Jack Na und 1 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Superbug Solutions, Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland, Australia. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Plague, caused by the Gram-negative bacterium Yersinia pestis, remains one of the most consequential infectious diseases in human history. Often regarded as a disease of the past, plague remains endemic in parts of Africa, Asia, and the Americas, with Madagascar and the Democratic Republic of the Congo reporting the majority of cases.1 Standard antimicrobials remain effective if treatment is prompt, yet limited diagnostic and health-system capacity in remote endemic settings makes timely treatment difficult to guarantee.
Autor:innen und Institutionen
- Centre for Superbug Solutions, Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland, Australia.
- Centre for Superbug Solutions, Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland, Australia. Electronic address: mark.walker@uq.edu.au.
Zitieren
APA
Na, J., & Walker, M. J. (2026). A one-shot mRNA-LNP vaccine approach to prevent plague?. eBioMedicine, 134, 106567. https://doi.org/10.1016/j.ebiom.2026.106567
Vancouver
Na J, Walker MJ. A one-shot mRNA-LNP vaccine approach to prevent plague?. eBioMedicine. 2026;134:106567. doi:10.1016/j.ebiom.2026.106567
BibTeX
@article{Na2026,
author = {Na, Jack and Walker, Mark J},
title = {A one-shot mRNA-LNP vaccine approach to prevent plague?},
journal = {eBioMedicine},
year = {2026},
volume = {134},
pages = {106567},
doi = {10.1016/j.ebiom.2026.106567}
}
EUVIMED